Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG vs 99mTc for Axillary Lymphatic Mapping in Breast Cancer
NCT02419807Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Feb 2015
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of indocyanine green in breast cancer, sponsored by Case Comprehensive Cancer Center. Primary endpoint: Proportion of Sentinel Lymph Nodes (SLNs) Flagged by the Two Methods. Started Feb 2015; status: completed.
02
Drugs
indocyanine green
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02419807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02419807.